Life Sciences

Olympus is set to begin the next phase of construction on its new Westborough facility following a topping-off ceremony.

Sanofi will celebrate the grand opening of a new manufacturing facility in Framingham today in a ceremony that will be attended by Gov. Charlie Baker.

Gardner biomanufacturer New England Peptide has received a majority recapitalization from Wellesley private equity firm Ampersand Capital Partners, as the company sets its sights on continued expansion.

Or-Genix Therapeutics, a Worcester-based dermatology company, has scored a partnership with Spain-based Fission Labs for the transfer and development of a topical skin care solution.

Marlborough drugmaker Phio Pharmaceuticals is partnering with a Philadelphia biotech on a research collaboration to help evaluate the company’s scientific platform for use in cancer treatment.

Harvard Bioscience closed Monday trading up more than 10% after the Holliston biotech released a strategic action plan and financial targets through 2021.

Franklin joint-replacement company Arthrosurface has continued its recent string of product innovation by releasing a new toe implant that recently received federal clearance. 

The scientific founder of a Southborough startup pharmaceutical company has landed a $3.8 million grant from the U.S. Department of Defense to help develop a drug to treat traumatic brain injury and concussions. 

Marlborough medical device maker Hologic has made a final offer to acquire the remaining shares of a French ultrasound manufacturer about a month after purchasing nearly half of the company’s shares. 

Doctors at UMass Memorial Medical Center in Worcester are the first in New England to use a newly approved device that has been used in only 3,000 procedures to treat aneurysms.